All Practice Exams

Free Practice Questions for Egyptian Board Cardiology

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Sample Egyptian Board Cardiology Practice Questions

Try these sample questions to review concepts for the Egyptian Board Cardiology exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1On the standard cardiac Wiggers diagram, which mechanical event immediately follows the closure of the atrioventricular (mitral and tricuspid) valves and precedes the opening of the semilunar (aortic and pulmonic) valves?
A.Isovolumetric ventricular contraction
B.Rapid ventricular ejection phase
C.Isovolumetric ventricular relaxation
D.Diastasis (slow ventricular filling)
Explanation: Isovolumetric contraction begins when ventricular pressure exceeds atrial pressure, causing mitral and tricuspid valve closure (first heart sound, S1). During this interval, all four cardiac valves are closed, and ventricular pressure rises steeply at constant volume until it exceeds aortic and pulmonary arterial pressures, forcing the semilunar valves to open.
2A 45-year-old patient receives an intravenous infusion of dobutamine during hemodynamic monitoring. How does an isolated increase in myocardial contractility (inotropy) alter the left ventricular pressure-volume loop?
A.Shifts the end-systolic pressure-volume relationship (ESPVR) downward and to the right
B.Shifts the end-systolic pressure-volume relationship (ESPVR) upward and to the left, increasing stroke volume
C.Shifts the end-diastolic pressure-volume relationship (EDPVR) upward without changing end-systolic elastance
D.Widens the loop exclusively by increasing the end-diastolic volume at a fixed end-systolic volume
Explanation: Increased inotropic state (contractility) steepens and shifts the end-systolic pressure-volume relationship (ESPVR, or Ees) upward and to the left. As a result, the ventricle empties more completely against a given afterload, leading to a reduced end-systolic volume and an increased stroke volume.
3In a patient experiencing an acute hypertensive crisis with sudden elevation of systemic vascular resistance, what primary change is observed on the left ventricular pressure-volume loop?
A.Decrease in peak systolic pressure accompanied by increased stroke volume
B.Narrowing of the loop due to isolated reduction in end-diastolic volume
C.Increase in peak ventricular systolic pressure, increased end-systolic volume, and reduced stroke volume
D.Immediate leftward displacement of the end-systolic pressure-volume relationship
Explanation: An acute increase in afterload (effective arterial elastance, Ea) causes the left ventricle to contract against greater impedance. The ventricle reaches a higher peak systolic pressure, ejects less blood during systole (higher end-systolic volume), and consequently experiences a decrease in stroke volume and ejection fraction.
4Regarding the physiological regulation of coronary blood flow, during which phase of the cardiac cycle does the majority of left ventricular myocardial perfusion occur, and which anatomical layer is most vulnerable to ischemia during tachycardia?
A.Systole; subepicardium
B.Systole; mid-myocardium
C.Diastole; subepicardium
D.Diastole; subendocardium
Explanation: During ventricular systole, high intramyocardial tissue pressure compresses the intramural coronary arterioles, virtually halting left ventricular subendocardial blood flow. Consequently, more than 75-80% of left ventricular perfusion occurs during diastole; tachycardia disproportionately shortens diastolic perfusion time, rendering the subendocardium highly vulnerable to ischemia.
5What is the primary cellular biophysical mechanism underlying the Frank-Starling law of the heart when resting sarcomere length increases from 1.8 to 2.2 micrometers?
A.Increased phosphorylation of phospholamban by protein kinase A
B.Increased calcium sensitivity of cardiac troponin C and optimal myofilament overlap
C.Direct activation of the sodium-calcium exchanger running in reverse mode
D.Augmented sarcoplasmic reticulum calcium content via ryanodine receptor upregulation
Explanation: The Frank-Starling mechanism is governed by length-dependent activation. Stretching cardiac myocytes to optimal sarcomere lengths (~2.2 um) reduces interfilament lattice spacing and increases the affinity of cardiac troponin C (cTnC) for calcium, producing greater cross-bridge recruitment and force development without requiring an increase in intracellular calcium concentration.
6A 58-year-old male in the cardiac intensive care unit undergoes right heart catheterization. His resting oxygen consumption (VO2) is measured at 240 mL/min. Arterial blood gas shows hemoglobin 15 g/dL with arterial oxygen saturation (SaO2) of 98%. Mixed venous oxygen saturation (SvO2) from the pulmonary artery is 68%. Assuming an oxygen-binding capacity of 1.34 mL O2/g Hb, what is his cardiac output calculated via the direct Fick principle?
A.3.0 L/min
B.4.0 L/min
C.5.5 L/min
D.6.8 L/min
Explanation: Arterial O2 content (CaO2) = 15 x 1.34 x 0.98 = 19.70 mL O2/dL (197 mL O2/L). Mixed venous O2 content (CvO2) = 15 x 1.34 x 0.68 = 13.67 mL O2/dL (136.7 mL O2/L). The arteriovenous oxygen difference (C[a-v]O2) = 19.70 - 13.67 = 6.03 mL O2/dL = 60.3 mL O2/L. Applying the Fick formula: Cardiac Output = VO2 / (CaO2 - CvO2) = 240 / 60.3 = 3.98 L/min, which rounds to 4.0 L/min.
7During an oximetric catheter run in a 32-year-old woman evaluated for an intracardiac shunt, the following oxygen saturations are recorded: Superior vena cava = 68%, Inferior vena cava = 74%, High right atrium = 84%, Mid right atrium = 85%, Low right atrium = 84%, Right ventricle = 85%, Pulmonary artery = 85%, and Systemic aorta = 97%. What is the location of the shunt and the calculated pulmonary-to-systemic flow ratio (Qp:Qs)?
A.Ventricular septal defect; Qp:Qs = 1.5:1
B.Patent ductus arteriosus; Qp:Qs = 2.0:1
C.Atrial septal defect; Qp:Qs = 2.0:1
D.Partial anomalous pulmonary venous return; Qp:Qs = 1.2:1
Explanation: Mixed venous saturation (Flamm formula) = (3 x SVC + 1 x IVC)/4 = (3x68 + 74)/4 = 70%. An oxygen step-up from 70% in mixed venous blood to 84-85% in the right atrium (>= 7% step-up) diagnosticates a left-to-right shunt at the atrial level (atrial septal defect). Qp:Qs = (SaO2 - SmvO2) / (SpvO2 - SpaO2) = (97 - 70) / (97 - 85) = 27 / 12 = 2.25:1, matching a hemodynamically significant ASD with Qp:Qs > 2.0:1.
8According to the Gorlin formula used in invasive cardiac catheterization to determine stenotic orifice areas, which physiological variable resides in the denominator under a square root function?
A.Mean transvalvular pressure gradient (delta P)
B.Systolic ejection period in seconds per beat
C.Heart rate in beats per minute
D.Cardiac output in milliliters per minute
Explanation: The Gorlin formula states: Valve Area = Flow / (C x sqrt[delta P]), where Flow is cardiac output divided by systolic ejection period (for aortic valve) or diastolic filling period (for mitral valve), C is an empirical discharge coefficient (44.3 for aortic, 37.7 for mitral), and delta P is the mean transvalvular pressure gradient. Thus, the square root of the mean pressure gradient is the denominator component.
9In elderly individuals, arterial wall stiffening due to elastin fragmentation and collagen accumulation leads to early return of wave reflections to the ascending aorta. What is the characteristic hemodynamic consequence of this phenomenon?
A.Increased diastolic blood pressure with narrowed central pulse pressure
B.Augmentation of central aortic systolic pressure and reduction of coronary perfusion pressure
C.Selective attenuation of peripheral systolic blood pressure relative to central pressure
D.Prolongation of left ventricular ejection duration without alteration in peak wall stress
Explanation: In stiff arteries, pulse wave velocity increases significantly, causing the reflected pressure wave from peripheral branching sites to return early during late systole rather than diastole. This produces late-systolic pressure augmentation in the ascending aorta (increasing left ventricular afterload and myocardial oxygen demand) while decreasing aortic diastolic pressure, which compromises coronary perfusion.
10A 60-year-old female with severe functional tricuspid regurgitation undergoes jugular venous pressure evaluation. What waveform abnormality is characteristically detected on her jugular venous pulse tracing?
A.Prominent 'a' wave with blunted 'v' wave
B.Steep 'x' descent with absent 'y' descent
C.Prominent fused 'c-v' regurgitant wave with loss of the systolic 'x' descent
D.Slow, sluggish 'y' descent following a normal 'v' wave
Explanation: In severe tricuspid regurgitation, retrograde systolic blood flow from the right ventricle into the right atrium obliterates the normal systolic 'x' descent and fuses the 'c' and 'v' waves into a large, positive systolic regurgitant wave (often called a 'c-v' or 's' wave), followed by a rapid, steep 'y' descent.

About the Egyptian Board Cardiology Exam

The Egyptian Board in Cardiology is the definitive national postgraduate certification in cardiovascular medicine awarded by the Egyptian Health Council under Law No. 12 of 2022. It assesses comprehensive mastery of cardiovascular physiology and hemodynamics (Part 1), clinical decision-making, pharmacotherapy, and coronary/structural interventions (Part 2), and bedside clinical examination and multimodal imaging interpretation (Part 3). This 100-question practice bank serves as an English-language study aid focused on the cognitive and analytical competencies tested in Part One and Part Two, including ECG rhythm analysis, hemodynamic calculations, guideline-directed medical therapy, and acute cardiovascular emergency algorithms.

Exam sponsor: Egyptian Health Council — Egyptian Board. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Egyptian Board in Cardiology (البورد المصري في أمراض القلب والأوعية الدموية) is administered by the Egyptian Health Council (EHC) under Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023. The certification pathway encompasses three sequential assessment components: Part One (applied basic cardiovascular sciences: physiology, hemodynamics, cardiac pharmacology, electrophysiology, and anatomy, held in March and August); Part Two (advanced clinical cardiology single-best-answer written MCQs, held in April and September); and Part Three (clinical OSCE stations, echocardiography and ECG data interpretation stations, and structured oral case discussions, held in December and January). Written papers are scored using psychometric standard-setting methods (Angoff/Modified Angoff or Hofstee), while Part Three utilizes borderline regression.

Time Limit

Varies by examination part

Passing Score

Set by psychometric standard-setting (Angoff/Hofstee method); no fixed percentage published

Exam / Certification Fees

Set periodically by the Egyptian Health Council under Prime Ministerial Decree No. 3798 of 2023 for each examination part (separate fees apply for Part One, Part Two, and Part Three).

Exam sponsor website

Reported exam pass rate: Determined annually through criterion-referenced standard-setting committees; not publicly released as a fixed time-series.. EHC establishes passing thresholds for each sitting using psychometric standard-setting panels rather than arbitrary numerical cutoffs. Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

12% of exam

Cardiovascular Physiology & Hemodynamics (Part One)

Cardiac cycle phases, Wiggers diagram, ventricular pressure-volume loops, preload/afterload/contractility, coronary blood flow regulation, Fick principle, shunt calculations (Qp:Qs), and Gorlin/Hakki valve area formulas.

8% of exam

Cardiac Anatomy, Embryology & Pathology (Part One)

Coronary artery architecture, congenital coronary anomalies, cardiac conduction tissue, autonomic innervation, pericardium, cardiac embryology/looping, atheroma biology, and cardiomyopathy histopathology.

10% of exam

Cardiovascular Pharmacology & Electrophysiology Basics (Part One)

Antiarrhythmic mechanisms (Vaughan Williams classes), inotropes, vasopressors, vasodilators, novel anticoagulants, antiplatelets, lipid-lowering therapies, cardiac action potential ion currents (INa, ICa-L, IKr, IKs, If), and effective refractory periods.

18% of exam

Acute Coronary Syndromes & Chronic Coronary Disease (Part Two)

STEMI, NSTEMI, unstable angina, MINOCA, high-sensitivity troponin algorithms, primary PCI timing, post-MI mechanical complications, dual antiplatelet strategies, chronic coronary syndromes, and revascularization guidelines (CABG vs PCI).

16% of exam

Heart Failure, Cardiomyopathies & Pericardial Diseases (Part Two)

HFrEF GDMT four pillars (ARNI, beta-blocker, MRA, SGLT2i), HFmrEF, HFpEF diagnostic criteria, cardiogenic shock SCAI stages, hypertrophic cardiomyopathy, cardiac amyloidosis (ATTR/AL), acute pericarditis, tamponade, and constriction.

12% of exam

Cardiac Arrhythmias, Electrophysiology & Device Therapy (Part Two)

Atrial fibrillation and flutter (rate vs rhythm control, CHA2DS2-VASc stroke prophylaxis, catheter ablation), SVTs (AVNRT, AVRT, WPW), ventricular tachycardia and storm, bradyarrhythmias, pacemaker indications, ICD criteria, and CRT indications.

10% of exam

Valvular Heart Disease & Infective Endocarditis (Part Two)

Severe aortic stenosis assessment, low-flow low-gradient AS, TAVR vs SAVR decision-making, aortic regurgitation, mitral stenosis Wilkins scoring, mitral regurgitation repair vs transcatheter edge-to-edge repair (TEER), and modified Duke criteria for endocarditis.

5% of exam

Adult & Pediatric Congenital Heart Disease (Part Two)

Atrial septal defect types and closure criteria, ventricular septal defects, patent ductus arteriosus, coarctation of the aorta, tetralogy of Fallot repairs and pulmonary regurgitation, Ebstein anomaly, and Eisenmenger syndrome.

5% of exam

Vascular Medicine, Systemic & Pulmonary Hypertension (Part Two)

Secondary hypertension diagnostic algorithms, hypertensive emergencies, acute aortic syndromes (Type A/B dissection), peripheral artery disease, pulmonary arterial hypertension risk stratification and targeted therapies, and acute pulmonary embolism management.

4% of exam

Cardiovascular Imaging & Invasive Hemodynamics (Part Two)

Echocardiographic Doppler quantification, cardiovascular magnetic resonance late gadolinium enhancement, coronary CTA, nuclear perfusion imaging, invasive coronary angiography, fractional flow reserve (FFR/iFR), and intravascular imaging (IVUS/OCT).

Preparing for the Egyptian Board Cardiology Exam

What You Need to Know

  • Passing score: Set by psychometric standard-setting (Angoff/Hofstee method); no fixed percentage published
  • Assessment: The Egyptian Board in Cardiology (البورد المصري في أمراض القلب والأوعية الدموية) is administered by the Egyptian Health Council (EHC) under Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023. The certification pathway encompasses three sequential assessment components: Part One (applied basic cardiovascular sciences: physiology, hemodynamics, cardiac pharmacology, electrophysiology, and anatomy, held in March and August); Part Two (advanced clinical cardiology single-best-answer written MCQs, held in April and September); and Part Three (clinical OSCE stations, echocardiography and ECG data interpretation stations, and structured oral case discussions, held in December and January). Written papers are scored using psychometric standard-setting methods (Angoff/Modified Angoff or Hofstee), while Part Three utilizes borderline regression.
  • Time limit: Varies by examination part
  • Exam / certification fees: Set periodically by the Egyptian Health Council under Prime Ministerial Decree No. 3798 of 2023 for each examination part (separate fees apply for Part One, Part Two, and Part Three). Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Egyptian Board Cardiology: Suggested Study Strategy

1Master cardiovascular hemodynamics for Part One, focusing on pressure-volume loops, Wiggers diagram timing, cardiac output calculations (Fick principle), and shunt equations (Qp:Qs).
2Study guideline-directed medical therapy (GDMT) algorithms from ESC and ACC/AHA guidelines for heart failure (four-pillar foundation), acute coronary syndromes, and dyslipidemia.
3Review high-yield electrocardiograms thoroughly, paying close attention to wide-complex tachycardia differentiation (Brugada and Vereckei criteria), channelopathies (Brugada, Long QT), and STEMI equivalents (de Winter, Wellens, Sgarbossa).
4Understand the hemodynamic and echocardiographic thresholds for intervention in valvular heart disease, particularly low-flow low-gradient aortic stenosis and secondary mitral regurgitation.
5Practice single-best-answer clinical vignettes with calculated hemodynamic parameters to improve speed and diagnostic precision on multi-step management questions.

Frequently Asked Questions

What is the official structure of the Egyptian Board in Cardiology?

The Egyptian Board certification in Cardiology under the Egyptian Health Council (EHC) comprises three distinct examination tiers: Part One tests applied basic cardiovascular sciences (cardiac physiology, hemodynamics, anatomy, pathology, electrophysiology, and pharmacology); Part Two evaluates advanced clinical cardiology through single-best-answer written MCQs; and Part Three consists of an objective structured clinical examination (OSCE), echocardiography/ECG data interpretation stations, and oral viva boards.

How are the passing scores determined for the Egyptian Board Cardiology exams?

Passing scores are established using psychometric standard-setting methodologies rather than arbitrary fixed percentages. Written papers in Part One and Part Two are set using the Angoff, Modified Angoff, or Hofstee methods, while the Part Three clinical OSCE uses the Borderline Regression Method.

Does this practice question bank prepare candidates for the Part Three clinical examination?

No. Part Three of the Egyptian Board is a live clinical examination assessing physical examination skills, procedural fluency, and real-time echocardiographic/angiographic interpretation. This 100-question practice bank is an English-language study aid dedicated to the cognitive knowledge, diagnostic test interpretation, and clinical management required in Part One and Part Two written papers.

What legal framework governs the Egyptian Board Cardiology specialty certification?

The Egyptian Board is the official national qualification governed by Egyptian Health Council Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023, unifying postgraduate medical training, accreditation, and board examinations across Egypt.

When are the Egyptian Board cardiology examinations held each year?

Typically, Part One written examinations are conducted in March and August; Part Two clinical written examinations take place in April and September; and Part Three clinical OSCE/data interpretation examinations are scheduled in December and January.